Login / Signup

Contraction of T cell richness in lung cancer brain metastases.

Aaron S MansfieldHongzheng RenShari SutorVivekananda SarangiAsha NairJaime I DavilaLaura R ElsberndJulia B UdellRoxana S DroncaSean S ParkSvetomir N MarkovicZhifu SunKevin C HallingWendy K NevalaMarie Christine AubryHaidong DongJin Jen
Published in: Scientific reports (2018)
Very little is known about how the adaptive immune system responds to clonal evolution and tumor heterogeneity in non-small cell lung cancer. We profiled the T-cell receptor β complementarity determining region 3 in 20 patients with fully resected non-small cell lung cancer primary lesions and paired brain metastases. We characterized the richness, abundance and overlap of T cell clones between pairs, in addition to the tumor mutation burden and predicted neoantigens. We found a significant contraction in the number of unique T cell clones in brain metastases compared to paired primary cancers. The vast majority of T cell clones were specific to a single lesion, and there was minimal overlap in T cell clones between paired lesions. Despite the contraction in the number of T cell clones, brain metastases had higher non-synonymous mutation burdens than primary lesions. Our results suggest that there is greater richness of T cell clones in primary lung cancers than their paired metastases despite the higher mutation burden observed in metastatic lesions. These results may have implications for immunotherapy.
Keyphrases
  • brain metastases
  • small cell lung cancer
  • squamous cell carcinoma
  • smooth muscle
  • lymph node
  • risk factors
  • wastewater treatment
  • microbial community
  • antibiotic resistance genes